Cardiogen-82
Payments companies reported to CMS as associated with Cardiogen-82. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cardiogen-82, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cardiogen-82
These are the largest totals companies reported as associated with Cardiogen-82. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Timothy Bateman | Kansas City, MO | Nuclear Cardiology | $41,849.00 |
| Sergey Kachur | Pensacola, FL | Cardiovascular Disease | $8,206.08 |
| Nils Johnson | Houston, TX | Cardiovascular Disease | $3,255.13 |
| Robert Bober | Oakland, CA | Cardiovascular Disease | $480.80 |
| Merrill Stewart | New Orleans, LA | Cardiovascular Disease | $94.71 |
| Surya Rao | Edgewater, FL | Cardiovascular Disease | $59.85 |
| Jaime Burkle | Gainesville, GA | Cardiovascular Disease | $38.53 |
| Robert Biederman | Charleston, SC | Cardiovascular Disease | $36.65 |
| Douglas Hill | Tupelo, MS | Cardiovascular Disease | $32.75 |
| William Calhoun | Tupelo, MS | Cardiovascular Disease | $32.75 |
Prescribed Cardiogen-82?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.